 | Up a level |
Journal Article
Al-Batran, Salah-Eddin, Homann, Nils, Pauligk, Claudia, Illerhaus, Gerald, Martens, Uwe M., Stoehlmacher, Jan, Schmalenberg, Harald, Luley, Kim B., Prasnikar, Nicole, Egger, Matthias, Probst, Stephan, Messmann, Helmut, Moehler, Markus, Fischbach, Wolfgang, Hartmann, Joerg T., Mayer, Frank, Hoeffkes, Heinz-Gert, Koenigsmann, Michael, Arnold, Dirk 
ORCID: 0000-0002-5325-8182, Kraus, Thomas W., Grimm, Kersten, Berkhoff, Stefan, Post, Stefan, Jager, Elke, Bechstein, Wolf ORCID: 0000-0002-3267-8145, Ronellenfitsch, Ulrich, Moenig, Stefan and Hofheinz, Ralf D.
(2017).
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer The AIO-FLOT3 Trial.
JAMA Oncol., 3 (9).
S. 1237 - 1245.
CHICAGO:
AMER MEDICAL ASSOC.
ISSN 2374-2445
Schuhmacher, Christoph, Gretschel, Stephan, Lordick, Florian, Reichardt, Peter, Hohenberger, Werner, Eisenberger, Claus F., Haag, Cornelie, Mauer, Murielle E., Hasan, Baktiar, Welch, John, Ott, Katja, Hoelscher, Arnulf, Schneider, Paul M., Bechstein, Wolf ORCID: 0000-0002-3267-8145, Wilke, Hans, Lutz, Manfred P., Nordlinger, Bernard, Van Cutsem, Eric, Siewert, Joerg R. and Schlag, Peter M.
(2010).
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954.
J. Clin. Oncol., 28 (35).
S. 5210 - 5219.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Sinn, Marianne, Bahra, Marcus, Liersch, Torsten, Gellert, Klaus, Messmann, Helmut, Bechstein, Wolf ORCID: 0000-0002-3267-8145, Waldschmidt, Dirk, Jacobasch, Lutz, Wilhelm, Martin, Rau, Bettina M., Gruetzmann, Robert, Weinmann, Arndt ORCID: 0000-0003-1198-1716, Maschmeyer, Georg, Pelzer, Uwe ORCID: 0000-0001-9213-2737, Stieler, Jens M., Striefler, Jana K., Ghadimi, Michael, Bischoff, Sven, Doerken, Bernd, Oettle, Helmut and Riess, Hanno
(2017).
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial.
J. Clin. Oncol., 35 (29).
S. 3330 - 3341.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755